Gene editing: The next frontier in America’s abortion wars
By Sarah Karlin,
Politico
| 02. 16. 2016
[cites CGS' Marcy Darnovsky]
Untitled Document
Longtime combatants find themselves on the same side when it comes to manipulating the DNA of human embryos.
That may seem like an idea from a sci-fi flick, but it’s already here. The gene-editing technique is already used in research and has the potential to modify human DNA with unprecedented ease in the not-too-distant future. British regulators approved limited experiments in human embryos earlier this month.
The technology holds promise to cure diseases like cystic fibrosis or sickle cell and even revive extinct species. But critics fear it could also be harnessed to craft “designer babies,” who are more intelligent, beautiful or athletic and to “edit” embryonic cells to change an inherited trait forever.
Those dystopian prospects have aligned U.S. groups long at odds: The anti-abortion Susan B. Anthony List, Family Research Council and the Center for Bioethics and Culture oppose gene editing in embryos. So do abortion rights groups like Our Bodies Ourselves and the leadership of the Pro Choice Alliance for Responsible Research, albeit for very different reasons.
They’re not alone in raising concerns. Scientists...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...